Gastric cancer is one of the most common malignant
tumors in China. This paper focuses on the development of
a DNA vaccine containing four mimotopes of MG7Ag for
gastric cancer (multi-
epitope vaccine). By inoculating BALB/c mice, the
vaccine was characterized and compared with a similar
vaccine containing only one mimotope (mono-
epitope vaccine) and other controls. Cellular ELISA indicated that serum titer of antibody against MG7Ag was significantly higher in mice immunized with the multi-
epitope vaccine than that in the group immunized with the mono-
epitope vaccine (0.8627 vs 0.6754, P < 0.05). And ELISPOT assay showed that the number of INF-gamma spots induced by multi-
epitope vaccine was significantly larger than that of the group immunized with mono-
epitope vaccine(93.3 vs 70.7, P < 0.05). Two weeks after
tumor challenge, the weight of
tumor in each mouse was evaluated, and the
tumor masses formed in the mice immunized with multi-
epitope vaccine were markedly smaller than those formed in the mice immunized with mono-
epitope vaccine. These studies demonstrated that both humoral and cellular response were induced by the two
vaccines and the efficiency of multi-
epitope vaccine is stronger than that of the mono-
epitope vaccine.